The economic burden of diabetes and the benefits of improved glycemic control: the potential role of a continuous glucose monitoring system.
Skyler
J S
JS
Department of Medicine, University of Miami, Florida 33101, USA. jskyler@miami.edu
D000328:Adult; D001786:Blood Glucose / Q000032:analysis* / Q000378:metabolism; D015190:Blood Glucose Self-Monitoring / Q000191:economics / Q000379:methods*; D003365:Costs and Cost Analysis; D003920:Diabetes Mellitus / Q000097:blood* / Q000191:economics* / Q000453:epidemiology; D003922:Diabetes Mellitus, Type 1 / Q000097:blood / Q000191:economics; D003924:Diabetes Mellitus, Type 2 / Q000097:blood / Q000191:economics; D017719:Diabetic Foot / Q000453:epidemiology; D003928:Diabetic Nephropathies / Q000453:epidemiology; D003930:Diabetic Retinopathy / Q000453:epidemiology; D006442:Glycated Hemoglobin / Q000032:analysis; D006801:Humans; D006973:Hypertension / Q000453:epidemiology; D015994:Incidence; D007676:Kidney Failure, Chronic / Q000453:epidemiology; D018670:Monitoring, Ambulatory / Q000191:economics / Q000379:methods*; D014481:United States / Q000453:epidemiology
D001786:Blood Glucose; D006442:Glycated Hemoglobin